UGT1A1*28 POLYMORPHISM AND VOMITING IN ADVANCED COLORECTAL CANCER

被引：0
|
作者：
El Bastawisy, A. E. [1 ]
Farid, S. F. [2 ]
Bahnasy, A. A. [1 ]
El Zeiny, A. M. [1 ]
机构：
[1] Cairo Univ, Natl Canc Inst, Med Oncol Dep, Giza, Egypt
[2] Cairo Univ, Fac Pharm, Giza, Egypt
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt459.153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dietary determinants of serum bilirubin in relation to UGT1A1*28 polymorphism.
    Peterson, S
    Bigler, J
    Horner, NK
    Potter, JD
    Lampe, JW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1922S - 1922S
  • [32] Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series
    Tsai, Hsiang-Lin
    Chen, Po-Jung
    Chen, Yen-Cheng
    Li, Ching-Chun
    Chang, Tsung-Kun
    Su, Wei-Chih
    Yin, Tzu-Chieh
    Huang, Ching-Wen
    Wang, Jaw-Yuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (07)
  • [33] Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy
    Liu, Xing-Han
    Lu, Jun
    Duan, Wei
    Dai, Zhi-Ming
    Wang, Meng
    Lin, Shuai
    Yang, Peng-Tao
    Tian, Tian
    Liu, Kang
    Zhu, Yu-Yao
    Zheng, Yi
    Sheng, Qian-Wen
    Dai, Zhi-Jun
    JOURNAL OF CANCER, 2017, 8 (04): : 691 - 703
  • [34] Frequency of the UGT1A1*28 Polymorphism in a Romanian Cohort of Gilbert Syndrome Individuals
    Radoi, Viorica E.
    Ursu, Radu I.
    Poenaru, Elena
    Arsene, Cosmin
    Bohiltea, Camil L.
    Bohiltea, Roxana
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2017, 26 (01) : 25 - 28
  • [35] THE POTENTIAL ROLE OF UGT1A1*28 POLYMORPHISM IN THE PATHOGENESIS OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Karakosta, M.
    Kalotychou, V.
    Zachaki, S.
    Daraki, A.
    Kostakis, A.
    Kouraklis, G.
    Manola, K.
    HAEMATOLOGICA, 2012, 97 : 516 - 517
  • [36] Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Heydari, Mohammad Reza
    Fardaei, Majid
    FRONTIERS IN PEDIATRICS, 2020, 7
  • [37] RACIAL DIFFERENCES IN THE ASSOCIATION BETWEEN UGT1A1*28 AND GENE EXPRESSION OF UGT1A1 AND SEARCHING FOR NOVEL REGULATORY VARIANTS OF UGT1A1
    Montalvo, A.
    Ferber, J.
    Collins, J.
    Wang, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S76 - S77
  • [38] Prevalence of UGT1A1*28 promoter polymorphism in the omani population: Implications for irinotecan treatment in GI cancer
    Al Ghoche, A. A. G.
    Al Zadjali, S.
    Pullanhi, A.
    Alfahdi, A.
    Al-Balushi, A.
    Al-Mahrouqi, N.
    Abu Omar, R.
    Salman, B.
    Almoundhri, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S208 - S209
  • [39] FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1*28 and*6 polymorphism: a multicenter, retrospective study
    Umemoto, Kumiko
    Takahashi, Hideaki
    Morizane, Chigusa
    Yamada, Ikuhiro
    Shimizu, Satoshi
    Shioji, Kazuhiko
    Yoshida, Yukio
    Motoya, Masayo
    Mizuno, Nobumasa
    Kojima, Yasushi
    Terashima, Takeshi
    Uesugi, Kazuhiro
    Ueno, Makoto
    Furuse, Junji
    Akimoto, Tetsuo
    Ikeda, Masafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (03) : 397 - 404
  • [40] FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study
    Kumiko Umemoto
    Hideaki Takahashi
    Chigusa Morizane
    Ikuhiro Yamada
    Satoshi Shimizu
    Kazuhiko Shioji
    Yukio Yoshida
    Masayo Motoya
    Nobumasa Mizuno
    Yasushi Kojima
    Takeshi Terashima
    Kazuhiro Uesugi
    Makoto Ueno
    Junji Furuse
    Tetsuo Akimoto
    Masafumi Ikeda
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 397 - 404
12345